Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
2 clinical trials · Condition
◉ Watch Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors (NCT07488676) | Astellas Pharma Global Development, Inc. | 2026-05-04 |
| A Pharmacokinetic Study of Zolbetuximab (IMAB362) in Chinese Subjects With Locally Advanced Unresectable or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma (NCT04086758) | Astellas Pharma China, Inc. | 2019-10-18 |
Track Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.